Introduction: Macroplastique has been used since 1993 for the endoscopic treatment of vesico-ureteric reflux in children with a failure rate per injected ureteric unit of 21%. The objective of this study was to analyse these failures on the basis of endoscopic findings on injection, ultrasound data at 2 months post-endoscopy and operative findings during the secondary reimplantation.
Material and methods: The authors retrospectively reviewed cases of failure of Macroplastique treatment from September 1993 to December 2002. Only children undergoing subsequent surgical reimplantation were included in the study: 60 cases (57 girls, 3 boys). Another 68 patients also presented recurrence of reflux, but are currently asymptomatic and have not been reoperated. Twenty five patients (42%) initially presented unilateral vesico-ureteric reflux: bilateral injection was performed in 17 of these cases because of the anatomical findings on endoscopy. In 92% of cases, the refluxing ureteric orifice appeared to be abnormal (in terms of position, appearance and the submucosal course of the ureter).
Results: Eleven children (18%) presented symptomatic or asymptomatic urinary tract infection before the first clinical and radiological review at 2 months. On the first ultrasound examination, the implant was visualized in the bladder wall in 71% of cases. At reimplantation, the bladder mucosa was inflammatory in 56 patients (94%). The ureteric orifice remained gaping in 38% of cases and the implant appeared to be modified (migration, decreased volume) in 35% of cases.
Conclusion: Failures of endoscopic treatment by Macroplastique can be due to persistence of pre-existing ureteric anatomical lesions (poor indication, technical error or difficulty) or modification of the injected product. Bladder inflammation and therefore previous or post-endoscopy urinary tract infections may also play a role.